ProPhase Labs (NASDAQ:PRPH) Stock Price Crosses Below Two Hundred Day Moving Average of $2.16

ProPhase Labs Inc (NASDAQ:PRPH)’s stock price crossed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $2.16 and traded as low as $1.99. ProPhase Labs shares last traded at $1.99, with a volume of 3,273 shares changing hands.

The stock has a 50-day moving average price of $1.91 and a 200 day moving average price of $2.16.

The firm also recently declared a dividend, which will be paid on Thursday, December 12th. Shareholders of record on Tuesday, December 3rd will be paid a $0.25 dividend. The ex-dividend date is Monday, December 2nd.

An institutional investor recently bought a new position in ProPhase Labs stock. Susquehanna International Group LLP acquired a new position in shares of ProPhase Labs Inc (NASDAQ:PRPH) during the 2nd quarter, according to its most recent filing with the SEC. The institutional investor acquired 13,717 shares of the company’s stock, valued at approximately $29,000. Susquehanna International Group LLP owned 0.12% of ProPhase Labs at the end of the most recent reporting period. 4.25% of the stock is owned by hedge funds and other institutional investors.

About ProPhase Labs (NASDAQ:PRPH)

ProPhase Labs, Inc engages in the research, development, manufacture, distribution, marketing, and sale of over-the-counter(OTC) consumer healthcare products, dietary supplements, and other remedies in the United States. The company offers TK Supplements product line include Legendz XL for sexual health; Triple Edge XL, an energy booster and testosterone support; and Super ProstaFlow+ for prostate and urinary health.

Further Reading: Moving Average Convergence Divergence (MACD)

Receive News & Ratings for ProPhase Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProPhase Labs and related companies with MarketBeat.com's FREE daily email newsletter.